Age-dependent differences in survival of patients with early breast cancer: analysis of SUCCESS A, B, C trials
Although elderly BC patients > 65 years had poorer survival, multivariable analysis suggests this difference is mostly attributable to advanced tumor stages rather than age itself. Effective BC screening and research related to the influence of (biological) age on response to cancer therapies could be the next step to improve understanding the relationship between patient age and BC survival.
Authors
- Davut Dayan (ORCID: https://orcid.org/0000-0003-1589-2016)
- Brigitte Rack (ORCID: https://orcid.org/0000-0002-7539-4839)
- Thomas W. P. Friedl (ORCID: https://orcid.org/0000-0002-4773-8067)
- Stefan Lukac (ORCID: https://orcid.org/0000-0002-9336-2267)
- Visnja Fink
- Elena Leinert
- A. Fink
- K. Pfister
- Wolfgang Janni
- Kristina Veselinovic
Institutions
- University Hospital Ulm (DE)
Publication Details
- Journal
- Archives of Gynecology and Obstetrics
- Published
- 2026-02-19
- DOI
- https://doi.org/10.1007/s00404-025-08255-5
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00